OLAParib COmbinations

NCT02576444 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
67
Enrollment
OTHER
Sponsor class

Stopped The study was paused during COVID and without the ability to initiate the 4th arm in the study, the decision was to terminate the study in 2022.

Conditions

Interventions

Sponsor

Joseph Paul Eder

Collaborators